Besides TP53 mutations [15,16], NOTCH1 and SF3B1, found in around 10% of newly diagnosed CLL patients, are the most frequently mutated genes [17,18]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.